HIGHLIGHTS
- who: Simone Huntingford from the Monash University have published the research: The elusive biomarker, in the Journal: (JOURNAL) of 30/06/2022
- future: Gervais et_al have certainly provided the groundwork for a number of future research directions.
SUMMARY
Previous studies have reported that preterm neonates also commonly receive fluid boluses. Of evolving concern is the link between anti-hypertensive therapy (including fluid boluses) and death and adverse neurodevelopmental outcome in preterm neonates. In the NICU, clinicians frequently balance the perceived benefits of fluid bolus therapy on systemic and cerebral perfusion, with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.